However, results show similar 5-year mortality rate across all grades of PPM and between native-valve vs. ViV TAVR
Patients with intermediate and high surgical risk who underwent transcatheter aortic valve replacement (TAVR) with balloon-expandable valves had higher rates of measured prosthesis-patient mismatch (PPMM) than PPM predicted (PPMP), and both PPMM and PPMP were reduced when the effective orifice area (EOA) was adjusted to body mass index (BMI), a new study shows.